DarioHealth Corp. (DRIO:NASDAQ) closed at $4.26 on October 20, 2026, down 5.33% on the day. The stock trades 74.1% below its 52-week high of $16.45 and 2.2% above its 52-week low of $4.17. Over the past year, it lost 71.9%. DarioHealth Corp. is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since October 17, 2025, DRIO closed higher on 117 days (46%). Its best day was October 20, 2025 (+22.79%) and its worst was April 7, 2026 (-16.51%). The stock moved 10% or more in a single session 16 times. It opened at least 5% above the previous day's high 2 times.
DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. Its flagship product is Dario Smart Diabetes Management Solution, a mobile, real-time, cloud-based, diabetes management solution based on a multi-feature software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device. The company is also pursuing patent applications in various jurisdictions covering the specific processes related to blood glucose level measurement, as well as various general methods of rapid tests of body fluids using mobile devices and cloud-based services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. The company was founded in 2011 and is headquartered in Caesarea, Israel.
Find more stocks like DRIO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.